Wiltrom Co. Ltd. · TPEX:6767
Wiltrom — Earnings Presentation (October 2025)
25 slides from Wiltrom's earnings presentation, October 2025
Slide 1: Wiltrom Co., Ltd
Stock Number: 6767 Wiltrom Co., Ltd 0
Slide 2: Outline
Outline I. Company profile II. Market overview and core technology platform III. Business performance VI. Business development strategy and future prospects 1
Slide 3: Company profile
Company profile Stock Num: 6767 Company Name Wiltrom Co., Ltd Establish Date 2009/12/18 1F., No.26, Sec. 2, Shengyi Rd., Zhubei City, Address Hsinchu County, 30261, Taiwan (R.O.C.) +886 3 6107168 Capital NTD$ 291,090,000 President &General Dr. Huang-Chien Liang Manager: Spinal Fixation System, Inter
Slide 4: Management team
經營團隊 President&General Manager Operation Management Ministry of Law Research and Development General Administration Sales & Marketing Department, Director Department, Director Department, Manager Department, Manager Department Manager PHD. Huang-Chien PHD. Hung-Ying, Tai Jessica Hsiao Rita Tsai Jack
Slide 5: Milestone
Milestone 2018 2021 2014 2019 2009 2016 The first Taiwanese brand company get TFDA approval of First Taiwan spine private Spine Minimally label enters US market OTC-listed company Invasive fixation First to develop patented system technology "Vertebral Body ITRI Technology Extension Augmentation Sys
Slide 6: Starting from Taiwan, enhancing international vision and building brand image
全球布局與銷售據點 Wiltrom Inc TAIWAN Taiwan Headquater, Biomedical Science Park(2009) Wiltrom Co., Ltd was established in 2009, and its products are under its own brand sales in more than 10 countries in the world. Customers in Europe, Asia, America and Africa. Starting from Taiwan, enhancing internationa
Slide 7: Company philosophy and vision
Company philosophy and vision • Core Value Innovation、Honesty、Health • Mission Provide safe and effective spinal innovative treatment methods, and jointly create health and well-being • Vision Become a leading company to provide total solution of spinal minimally invasive surgery solutions 6
Slide 8: Outline
Outline I. Company profile II. Market overview and core technology platform III. Business performance VI. Business development strategy and future prospects 7
Slide 9: Market overview - spinal surgery product market size
市場概況-脊椎手術相關產品市場規模 $ Million USD 8,290 Million 1,950 Million 1,520 Million 1,320 Million Spinal Fusion Vertebral Compression Spinal Non-Fusion Bone cement Surgery Frx Surgery Surgery Liquid Liquid Powder Global Spinal Fusion Global VCF Device Market Spinal Non-Fusion Surgery Surgery Market Markey Bon
Slide 10: Innovative R&D integration platform
創新研發整合平台 Market value, patent 3 Outer resource regulations, medical insurance system Produ 2 Experts analysis Safety Analysis Regulations ct Clinical 1 Material design 4 5 Com Unmet platform Need merci Mechanism design platform alized <Platform Features> 1. Continue to screen for valuable clinical u
Slide 11: Product Portfolio
Product Portfolio Vertebral Compression Spinal fusion surgery Frx. Surgery Bone Cement Spinal Fixation System Vertebral Bone Cement Augmentation System Interbody Fusion System Bone Graft Substitute 10
Slide 12: Development Trend of Spinal Fixation Surgery
Development Trend of Spinal Fixation Surgery Currently Clinical Unmet Need 開放式手術 經皮微創手術 How to complete spinal fusion surgery under a single small wound, implant spinal fixators, intervertebral fusion cages, and artificial replacement bones, shorten the patient’s hospital stay, and improve medical r
Slide 13: MIS Single-incision spinal fixation system
MIS Single-incision spinal fixation system The minimally invasive single-wound spinal fusion system can reduce the wound to 1.8cm, and achieve the completion of the operation under a single small wound in a limited field of view and operation area, shorten the patient's hospital stay and improve the
Slide 14: Development Trend of Vertebral compression fracture surgery
Development Trend of Vertebral compression fracture surgery Clinical Unmet NeedNeed to effectively provide vertebral body reduction and stabilize the vertebral body 85% 13% 2% The Spine Journal , 2015, 15, 281–289 Vertebroplasty Kyphoplasty Maintain the physiological curve of the spine and change
Slide 15: Vertebral Body Augmentation System (Tripod-Fix)
Vertebral Body Augmentation System(Tripod-Fix) The world's first corrective reduction for front-end compression fractures, effectively providing the reduction height of the vertebral body (21.0 ± 4.4%), avoiding the continued collapse of the vertebral body, and achieving the purpose of solving back
Slide 16: Bone cement
Bone cement Wiltrom uses process technology to stably control the particle size distribution of the powder, overcome the technical bottleneck of bone cement development, and sell it with vertebral spreaders to increase product penetration. It is one of the few medical equipment manufacturers in Asia
Slide 17: Outline
Outline I. Company profile II. Market overview and core technology platform III. Business performance VI. Business development strategy and future prospects 16
Slide 18: Develop research and development results with product differentiation
Develop research and development results with product differentiation 2014 2016 2017 2018 2019 2020 Bone Cement Tripod-Fix Bone-filling cage Single-incision spinal fixation system Saber-tooth interbody fusion system MIS spinal fixation system 17
Slide 19: Sales performance
Sales performance Domestic and foreign sales ratio (2020)-85:15 Domestic market: adopted by all major medical centers in Taiwan. Tripod-Fix also finished the hospital listing process in several medical centers. Foreign markets: Sales to more than ten countries including the United States, Chin
Slide 20: Financials
Financials > . WUTEEFOM se: sstn ease
Slide 21: Balance Sheets (Consolidated)
Balance Sheets (Consolidated) (In Thousands of New Taiwan Dollars) Current Ratio 671.86%，Liability Ratio 12.97%，Sound financial structure. 20
Slide 22: Income Statement (Consolidated)
Income Statement (Consolidated) (In Thousands of New Taiwan Dollars) ※ Compared with same period last year , Operating revenue increased 37% , and operating gross profit increased 52%, due to the growth of contract hospital sales, which reduced operating losses by 23%. ※ Current year increase in net
Slide 23: Outline
Outline I. Company profile II. Market overview and core technology platform III. Business performance VI. Business development strategy and future prospects 22
Slide 24: Future product development strategy
Future product development strategy Extension/continuity Spinal development products fusion Precision medicine (AI products navigation surgical robot) Innovative 3D printing composite R&D Vertebral Core technology compression integration extension products fracture product platform New R&D product S
Slide 25: Thanks for your attention
Thanks for your attention > . WUTEEFOM sec: sestn exis: